Dopamine-2 Receptor Antagonist [EPC]

5880 reported adverse events

Drugs of this class: DROPERIDOL AMISULPRIDE

These side effects are most commonly reported by patients taking drugs of the Dopamine-2 Receptor Antagonist [EPC] class:

# Side effect Count
0 DRUG INEFFECTIVE 695
1 DRUG INTERACTION 409
2 WEIGHT INCREASED 321
3 TOXICITY TO VARIOUS AGENTS 317
4 NEUTROPENIA 306
5 AKATHISIA 269
6 LEUKOPENIA 266
7 ELECTROCARDIOGRAM QT PROLONGED 260
8 SCHIZOPHRENIA 257
9 EXTRAPYRAMIDAL DISORDER 243
See all common reactions for Dopamine-2 Receptor Antagonist [EPC]

Drugs of the Dopamine-2 Receptor Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC 167 0.2835
1 REFUSAL OF EXAMINATION 23 0.1825
2 ANTIPSYCHOTIC DRUG LEVEL DECREASED 50 0.1176
3 DISINHIBITION 155 0.1072
4 ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC 54 0.0714
5 THERAPEUTIC PRODUCT EFFECT VARIABLE 131 0.0479
6 ANTIPSYCHOTIC DRUG LEVEL INCREASED 97 0.0407
7 SCHIZOAFFECTIVE DISORDER 49 0.0327
8 PLEUROTHOTONUS 26 0.0307
9 OROMANDIBULAR DYSTONIA 18 0.0304
See all enriched reactions for Dopamine-2 Receptor Antagonist [EPC]